Manga, Mary Grace M.

HRN: 11-98-34  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2025
CEFUROXIME 750MG (VIAL)
07/13/2025
07/19/2025
IV
750mg
Q12
Thinly MSAF
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines